Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ (1,000) $ 3,341,073
Adjustments to reconcile net income (loss) to net cash used in operations:    
Expensed offering costs 256,379
Net gain on investments held in Trust Account (1,747)
Change in fair value of warrant liabilities (4,037,000)
Changes in operating assets and liabilities:    
Prepaid expenses (583,799)
Accounts payable 75,024
Accrued expenses 1,000 102,370
Accrued offering expense 33,960
Accrued expense - related party 20,000
Franchise tax payable 24,034
Net cash used in operating activities (769,706)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (174,225,000)
Net cash used in investing activities (174,225,000)
Cash Flows from Financing Activities:    
Proceeds from promissory note - related party 188,302
Repayment of promissory note - related party (188,302)
Proceeds from initial public offering, net of underwriter’s discount paid 169,050,000
Proceeds from sale of private placement warrants 7,175,000
Payment of offering costs (466,282)
Proceeds from sale of Founder Shares 25,000
Net cash provided by financing activities 25,000 175,758,718
Net Change in Cash 25,000 764,012
Cash - Beginning of period 25,000
Cash - End of period 25,000 789,012
Supplemental disclosures of non-cash investing and financing activities:    
Initial classification of warrant liabilities $ 16,707,500